Haemostasis Flashcards

1
Q

why is haemostasis needed in blood?

A
  1. Coagulation following injury
  2. Prevention of extreme blood clotting (thrombosis)
  3. Fibrinolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the actions taken by the body to ‘halt’ the blood following trauma?

A
  • 3 intertwined processes
    1) Vasoconstriction
    2) primary haemostasis (unstable platelet plug)
    3) secondary haemostasis/coagulation (fibrin clot)
  • fibrin clot binds to platelet plug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is it important to understand these mechanisms?

A
  • blood disorders
  • risks of thrombosis
  • treat thrombotic disorders
  • monitor drug involved in bleeding
  • control bleeding in general pop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the steps that happen in response to injury?

A

Vasoconstriction → primary haemostasis → secondary haemostasis → fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what two processes does primary haemostats involve?

A
  • platelet adhesion

- platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what process does secondary haemostasis involve?

A

-formation of a fibrin clot (coagulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does fibrinolysis involve?

A

dissolution of the blood clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

where are platelets derived from?

A

myeloid stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the key features of platelets?

A
  • discoid
  • non-nucleated (classified as cell fragments)
  • granule-containing (alpha + dense granules)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe the process fo platelet adhesion (primary haemostasis part 1)

A

platelets stick to damaged endothelium following injury through one of two ways:

1) direct → glycoprotein-Ia (GPIa) receptor binding to collagen
2) indirect → GPIb + Von Willebrand factor binds to collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what does platelet adhesion cause?

A

1) activation
2) change in shape from disc → rounded with spicules (encourages interaction)
3) release action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what happens during the platelet release action?

A

after it is activated, releases contents of storage granules:

1) ADP
2) fibrinogen
3) von Willebrand factor
4) A2 thromboxane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the role of A2 thromboxane?

A
  • causes positive feedback in platelet recruitment + aggregation
  • vasoconstrictor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what happens during platelet aggregation?

A

A2 thromboxane + ADP → platelet activation → conformational change in receptors so fibrinogen can bind (ADP can expose a receptor which enables platelets to link together) → link platelets together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is inappropriate platelet aggregation avoided?

A
  • prostacyclin (powerful vasodilator)

- active blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

give two examples of antiplatelet drugs

A

1) aspirin → reduced platelet aggregation

2) clopidogrel → block ADP receptor

17
Q

what is the role of Von Willebrand factor?

A
  • glycoprotein
    1) mediates the adhesion of platelets to sites of injury (indirect platelet adhesion)

2)promotes platelet-platelet aggregation

18
Q

when is secondary haemostasis (coagulation) needed?

A

in larger vessels, platelet plug not strong enough so fibrin needed to stabilise it

19
Q

where are clotting factors synthesised?

A

-liver (except VWF + VIII made in endothelial cells)

20
Q

what three steps are involved in the synthesis of clotting factors?

A

initiation → amplification → propagation

21
Q

give three examples of 3 artificial anticoagulants

A

1) Heparin → Incr. antithrombin
2) Warfarin → Interfere with carboxylation
3) DOACs → Inhibit either thrombin or factor Xa

22
Q

give three examples of 3 natural anticoagulants

A
  • ensures coagulation is confined to site of injury
    1. antithrombin → inhibits thrombin + factor Xa
    2. protein C → becomes APC
    3. protein S → acts as a co-factor with activated protein C (APC)
23
Q

what is the primary fibrinolytic enzyme?

A

plasmin (circulates in the form on plasminogen)

24
Q

give a summary of secondary haemostasis

A

fibrinogen released by the platelets to fibrin using thrombin (preactivated form called prothrombin)

25
Q

how is plasminogen activated to plasmin?

A
  • tissue plasminogen activator

- plasminogen binding to lysine residues on fibrin clot

26
Q

what are the products of fibrin breakdown?

A

fibrin depredation products (FDP)

27
Q

how does tranexamic acid (and antifibrolytic drug) work?

A
  • derivative of lysine
  • competetive inhibitor of lysine so plasminogen can not bind to lysine
  • can not be activated to plasmin so reduced no of enzymes (plasmin) are produced to breakdown fibrin clot
28
Q

what are the two different test of coagulation?

A

1) measuring the integrity of the extrinsic pathway (prothrombin time)
2) measuring the integrity of the extrinsic pathway (APTT)

29
Q

What can cause an imbalance in haemostasis therefore a bleed?

A

1) Reduced platelet number/function (primary)

2) Reduction in coagulation factors (secondary)
→ VWF reduction = VW disease
→ Haemophilia A + B
→ Cause? Liver disease, anticoagulants, DIC (uncontrolled coagulation activation)

3) Incr. fibrinolysis
→ Cause? DIC, thrombolytic therapy

30
Q

how is the risk increased for venous thrombosis?

A

1) Reduced no. of anticoagulants ie. antithrombin
2) reduced levels of fibrinolysis (e.g. in prganancy)
2) Incr. clotting factors/platelets (i.e. Factor VIII incr during preganancy, mutation, myeloproliferative disorders)

31
Q

how is the risk increased for venous thrombosis?

A

1) Reduced no. of anticoagulants ie. antithrombin so more likely for coagulation to happen therefore more likely thrombosis
2) reduced levels of fibrinolysis (e.g. in prganancy)
2) Incr. clotting factors/platelets (i.e. Factor VIII incr during preganancy, mutation, myeloproliferative disorders)